Compare Matson Inc (MATX) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Matson Inc vs NeoGenomics Inc. Common Stock — how do they compare? Matson Inc trades at $235.22 (market cap $7.04B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: Matson Inc is far larger — about 3.2× NeoGenomics Inc. Common Stock's market cap, and Matson Inc pays a 0.65% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Matson Inc for 25 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| MATX | NEO | |
|---|---|---|
Market Cap | $7.04B | $2.17B |
Volume | 295,660 | 1,615,943 |
Sector | Industrials | Health |
52-Week High | $238.60 | $19.91 |
52-Week Low | $93.22 | $7.19 |
Typical Hold Time | 25 Days | 0 Days |
Enterprise Value | $7.64B | $2.47B |
Dividend Yield | 0.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Matson (MATX) trades at $235.22, up 3.31% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q2 2026 EPS of $4.27 vs. $3.79 expected) and improving profitability (13.41% net margin). Recent news highlights cost controls, dividend payments, and institutional accumulation, with Bank of New York Mellon acquiring a $50.6 million position in Q2 2026.
MATX presents a compelling growth story with 66.7% analyst buy ratings and 27.3% upside potential. Risks include freight market cyclicality and competitive pressures, but strong cash flow generation and share repurchases support shareholder returns. The stock's valuation remains reasonable at P/E of 15.9x with positive earnings momentum.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →
